|
|
||||||||
1From Ophthalmic Research, Cole Eye Institute, and the 6Imaging Core Laboratory, The Cleveland Clinic Foundation, Cleveland, Ohio; the 2Departments of Ophthalmology, 3Pharmacology, and 4Cell Biology, Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Florida; and 5Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts.
PURPOSE. This study was conducted to determine whether intrastromal injection of adenoviral construct could be used to transfect corneal stroma cells effectively in vivo and to determine whether a tissue-specific promoter could be used to express exogenous genes in keratocytes.
METHODS. An adenoviral construct with a cytomegalovirus (pCMV)-driven enhanced green fluorescent protein (EGFP) reporter gene was injected into the stroma of murine corneas. In vivo expression was quantitated and samples were analyzed by in vivo stereomicroscopy, and ex vivo expression was determined by confocal three dimensional (3-D) reconstruction. The 3.2-kb keratocan promoter was used to drive tissue-specific reporter gene expression in vivo.
RESULTS. EGFP expression was first detected in vivo 11 hours after injection of adeno-EGFP in the corneal stroma, with a duration of approximately 3 weeks. Ex vivo wholemount cornea confocal analysis with 3-D reconstruction allowed visualization of EGFP expression in corneal stroma cells, to accurately assess cellular architecture and distribution in the corneal stroma. Naked pCMV-EGFP plasmid DNA did not express the reporter gene to the levels of the adeno-EGFP. The 3.2-kb keratocan promoter was capable of driving EGFP tissue-specific expression in the cornea.
CONCLUSIONS. Intrastromal injection of adenovirus packaged DNA constructs is a rapid and efficient way to deliver and express genes in the corneal stroma. Intrastromal injection is also capable of delivering tissue-specific promoter constructs to the corneal stroma for gene expression. Furthermore, 3-D reconstruction provides a powerful tool for enhanced visualization of the corneal stroma environment and cellular biology.
This article has been cited by other articles:
![]() |
E. C. Carlson, M. Lin, C.-Y. Liu, W. W-Y. Kao, V. L. Perez, and E. Pearlman Keratocan and Lumican Regulate Neutrophil Infiltration and Corneal Clarity in Lipopolysaccharide-induced Keratitis by Direct Interaction with CXCL1 J. Biol. Chem., December 7, 2007; 282(49): 35502 - 35509. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Carlson, J. Drazba, X. Yang, and V. L. Perez Visualization and Characterization of Inflammatory Cell Recruitment and Migration through the Corneal Stroma in Endotoxin-Induced Keratitis Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 241 - 248. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Carlson, C.-Y. Liu, T.-i. Chikama, Y. Hayashi, C. W.-C. Kao, D. E. Birk, J. L. Funderburgh, J. V. Jester, and W. W.-Y. Kao Keratocan, a Cornea-specific Keratan Sulfate Proteoglycan, Is Regulated by Lumican J. Biol. Chem., July 8, 2005; 280(27): 25541 - 25547. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |